Transcript The WPA/WHO/IACAPAP Program on Global Child Mental Health

The Presidential World Psychiatric Association (WPA)
Program on Global Child Mental Health
Conducted in Collaboration with
The World Health Organization (WHO)
&
The International Association for Child and Adolescent
Psychiatry and Allied Professions (IACAPAP)
Current epidemiological data indicate that
one of five children and adolescents under
the age of 18 has a mental health
problem.
3-4% of this age group has a serious
mental disorder requiring treatment.
Only a small proportion of children and
adolescents affected by mental disorder
receive adequate care.
There is lack of awareness of the
magnitude and severity of the problems
caused by children mental disorders by:
- Political decision makers.
- Health decision makers.
- Health professionals.
- General Public.
At present there are only very few
countries with clear policies and plans
concerning child mental health.
Research on child mental health is poorly
supported.
OBJECTIVES OF THE PROGRAM (1):
To increase the awareness of health
decision-makers, health professionals and
the general public about the magnitude
and severity of problems related to mental
disorders in childhood and adolescence
and about possibilities for their resolution.
OBJECTIVES OF THE PROGRAM (2):
To promote the application of measures of
primary prevention of mental disorders in
childhood and adolescence and of
interventions that will contribute to the
healthy mental development of children
and adolescents.
OBJECTIVES OF THE PROGRAM (3):
To offer support to the development of
services for children and adolescence with
mental disorders and to facilitate the use
of effective methods of treatment.
PRODUCTS OF THE PROGRAM (1):
The publication of critical reviews of the
literature on child and adolescent mental
health and of information about relevant
programs in different countries.
Internationally-accepted guidelines for
activities promoting child and adolescent
mental health.
PRODUCTS OF THE PROGRAM (2):
Manuals and guidelines concerned with
the prevention, early recognition, detection
and treatment of mental disorders in
childhood for health professionals and
others concerned with child care and
upbringing (e.g. teachers, parents,
religious leaders, social welfare workers).
PRODUCTS OF THE PROGRAM (3):
A functional network of individuals and
institutions committed to the achievement
of the objectives of the program.
A data base containing information about
the current epidemiological situation and
about policies and programs relevant to
the promotion of child mental health in
different parts of the world.
TIMETABLE OF THE PROGRAM:
(Year 1)
1- The development of critical reviews of
information concerning
- The promotion of mental health of children
and adolescents.
- The prevention of mental disorders in
childhood.
- The organisation of services and treatment
of mental disorders in that age.
2- The establishment of the Child and
Adolescent Mental Health Network
composed of institutions and advisers.
3- The development of drafts of manuals and
guidelines concerned with child mental
health and the management of mental
disorders in childhood.
4- The establishment of alliances with
international and national organizations
relevant to the Program’s objectives.
TIMETABLE OF THE PROGRAM:
(Year 2)
1- The translation and field testing of the manuals
and guidelines.
2- The trial application of comprehensive child
mental health programs in selected countries.
3- The preparation of a policy-making conference
involving health decision makers as well as
experts in the field of mental health and various
relevant organizations.
TIMETABLE OF THE PROGRAM:
(Year 3)
1- The publication of the finalized manuals
and guidelines.
2- Support to the introduction and wide
application of manuals at country level.
3- The conduct of a policy conference to
present the products of the program and to
initiate the development of national child
mental health programs.
Members of the Steering Committee:
- Chairperson
A. Okasha (Egypt)
- Vice Chairperson
N. Sartorius (Switzerland)
- Scientific Director
H. Remschmidt (Germany)
- Scientific Vice Director
S. Tyano (Israel)
- Secretary
T. Okasha (Egypt)
- Members
P. Jensen (USA)
B. Nurcombe (Australia)
- WHO Representative
M. Belfer (Geneva)
- Eli Lilly Representative
J. Heiligenstein (USA)
Task force on Awareness
Chairperson: S. Tyano (Israel)
Members:
M. Belfer (Switzerland)
K. M. Hong (Korea)
J. Schaller (USA)
D. Wasserman (Sweden)
C. Hoven (USA)
D. Song (China)
T. Agoussou (WHO/AFRO)
Task force on Primary Prevention
Chairperson: H. Remschmidt (Germany)
Members:
L. Rohde (Brazil)
T. Dmitrieva (Russia)
P. Rydelius (Sweden)
A. Seif El-Din (Egypt)
M. Flament (Canada)
E. Caffo (Italy)
J. Cox (UK)
Task force on Health Services,
Management And Treatment
Chairperson: P. Jensen (USA)
Members:
S. F. Hung (China)
J. Fayyad (Lebanon)
J. Bauermeister (Puerto Rico)
R. Harrington (UK)
K. Kelleher (USA)
K. Hoagwood (USA)
PROGRAM FUNDING
This program is supported by:
1. An unrestricted educational grant from the
Eli Lilly and Company Foundation
2. Contributions of institutions and individuals
participating in the program.